Beijing Infervision Healthcare Medical Technology Co.

Company profile

About Beijing Infervision Healthcare Medical Technology Co.

Beijing Infervision Healthcare Medical Technology Co. is a global leader in AI-powered medical imaging solutions that support the entire patient care journey. Founded with the mission to improve human life through artificial intelligence, Infervision has developed a comprehensive suite of products spanning disease screening and diagnosis (InferRead®), surgical intervention and treatment planning (InferOperate®), and medical research platforms (InferScholar®). The company's flagship InferRead® CT Lung solution has achieved FDA 510(k) clearance, NMPA approval, and CE marking, demonstrating 99% sensitivity in AI-assisted lung nodule detection and reducing reading time by 33%. InferRead® DR Chest revolutionizes tuberculosis screening in high-burden countries, achieving 84.9% AUC and outperforming expert radiologists in field studies across Asia and Africa. The InferOperate® Suite provides fully automated 3D reconstruction for thoracic, liver, and urological surgeries, enabling surgeons to simulate procedures and identify anatomical variations with unprecedented precision. With over 380 patents filed, 330+ peer-reviewed publications, and deployments across 30+ countries, Infervision serves health systems, radiology practices, surgical departments, and research institutions worldwide. The company maintains offices across the globe and has established partnerships with leading healthcare organizations including SimonMed, Wake Radiology, and Sanford Health. Their solutions integrate seamlessly with existing PACS and RIS systems through browser-based viewers, supporting both on-premise and cloud-based deployment models.

Company description · Beijing Infervision Healthcare Medical Technology Co. official website